Stock News

aTyr Pharma to Present at the 2023 Jefferies Healthcare Conference
aTyr Pharma Presents New Data on Efzofitimod Mechanism of Action and Positive Exposure-Response at the American Thoracic Society 2023 International Conference
aTyr Pharma to Present at the 2023 RBC Capital Markets Global Healthcare Conference
aTyr Pharma Announces First Quarter 2023 Results and Provides Corporate Update
3 Stocks and Cryptos With the Highest Potential Returns
7 Hot Growth Stocks Poised to Triple in 2023
aTyr Pharma Presents Preclinical Research Demonstrating Treatment with ATYR2810 Inhibits Tumor Growth and Therapy Resistance in Highly Aggressive Cancers at the 2023 AACR Annual Meeting
aTyr Pharma Announces First Major Review Article for Efzofitimod Published in the Journal Sarcoidosis, Vasculitis and Diffuse Lung Diseases
2 “Strong Buy” Penny Stocks With Over 200% Upside on the Horizon
aTyr Pharma to Present Data Identifying Fibrosis Target for tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis Pathogenesis and Resolution
aTyr Pharma and Foundation for Sarcoidosis Research Announce Town Hall Virtual Meeting on Sarcoidosis and Transitioning from Steroids to New and Investigational Therapies
aTyr Pharma Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
aTyr Pharma to Present at March Investor Conferences
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2022 Financial Results

As seen on...